<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Neuropathic pain involves a lesion or disease of the nervous system and comprises numerous chronic pain conditions that involve different pathophysiological mechanisms (
 <xref rid="ref14" ref-type="bibr" class="xref">Cohen and Mao, 2014</xref>). The neuropathic pain management is challenging. Despite the availability of numerous treatment options, many patients suffer from pain that is refractory to available treatments. Evaluation of pharmacotherapy in randomized clinical trials showed that clinically significant pain relief was experienced only by half of patients, which is predominantly partial but not complete relief. In addition, patients very often experience heavy side effects, and as a consequence, they discontinue therapy (
 <xref rid="ref55" ref-type="bibr" class="xref">Vranken, 2012</xref>; 
 <xref rid="ref23" ref-type="bibr" class="xref">Finnerup etÂ al., 2015</xref>). Inappropriate response to drug treatment represents an important unmet need in neuropathic pain patients. Therefore, there is an urgent need to develop novel and more effective therapies for this condition.
</p>
